A recent report published by Infinium Global Research on the stem cell banking market provides in-depth analysis of segments and sub-segments in the global as well as regional stem cell banking market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional stem cell banking market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global stem cell banking market. According to the report, the global stem cell banking market is projected to grow at a CAGR of 8.36% over the forecast period of 2021-2027.

Market Insight

The global stem cell banking market was sized from USD 7.76 billion in 2021 to about USD 12.57 billion in 2027. The global stem cell banking market is projected to grow with a CAGR of 8.36% during 2021-2027. The cells which possess the potential to regenerate different types of cells in the body are called stem cells, and such cells serve as a repair system in the human body. Furthermore, embryonic stem cells and adult stem cells are stem cells. However, the collection and preservation of various types of stem cells like cord and adult stem cells for future applications are known as stem cell banking. Moreover, Stem cell banking is one of the most promising and fastest growing segments of next-generation stem cell therapy. It is used in tissue engineering, gene therapy, and regenerative medicines. In steam cell banking, stem cells need to undergo many processing and analysis procedures after collection. As a result, various genetics tests are conducted on steam cells to ensure diseases like leukemia and lymphomas.

The prime factors which are driving the growth of stem cell banking market are increase in R&D activities in regards with applications of stem cells, rise in number of fatal chronic diseases, and surge in disposable income of peoples. Furthermore, rise in gross domestic product (GDP) of respective underdeveloped and developing countries, increased birth-rate globally, and rise in fatal chronic diseases are anticipated to contribute in propelling the growth of the stem cell banking market over the forecast period. However, high operational costs of steam cell banking can hamper he market’s growth during forecast period. Additionally, stringent regulations set by the governments on steam cell banking can also restrain the growth of the stem cell banking market. Nevertheless, increasing approval of clinical trials in stem cell research and technological advancements are anticipated to provide lucrative growth opportunities to the stem cell banking market.

Based on the region, Stem cell banking market is segmented as North America, Europe, Asia Pacific and rest of the world. North America is dominating the stem cell banking market by holding the major share of the market owing to rise in prevalence of fatal chronic diseases, presence of multiple stem cell banks, and well-established healthcare infrastructure in the region. Furthermore, expanding network of stem cell banking services across the region, ongoing approval of stem cell lines for disease treatment (especially for hematopoietic & autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments for stem cell researches are other factors which are boosting market’s growth in the region. However, Asia-Pacific is expected to register the highest growth in the market owing to an increase in the number of new-born babies, and rise in healthcare expenditures.

Segment Covered

The report on global stem cell banking market covers segments such as cell type, service type, and application. On the basis of cell type, the sub-markets include PSC, BMSC, ADSC, HESC, DPSC, AND NSC. On the basis of service type, the sub-markets include collection and transportation, processing, analysis, and storage. On the basis of application, the sub-markets include personalized storage, and clinical.

Companies Profiled:

The report provides profiles of the companies in the market such as CBR Systems Inc., China Cord Blood Corporation, Cordlife, Cordvida, Cryo-Cell International, Inc., Cryo-Save AG (A Group of Esperite), Cryoviva India, Lifecell, Smart Cells International Ltd, and Viacord.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the stem cell banking market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.